Has Monica Vetter, MD received payments from drug or device companies?

Yes. Drug and device makers reported $21,684 in general payments to Monica Vetter, MD across 126 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Monica Vetter, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Monica Vetter, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Monica Vetter, MD

Gynecologic Oncology · Louisville, KYNPI 1811331390

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (37.2%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Intuitive Surgical at 52.8% of the total. 2025 is the largest year on record at $12,436, more than ten times the $125 reported in 2019. Among gynecologic oncology clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$21,684in general payments, 2019–2025

Across 126 payments — averaging $172.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intuitive Surgical$11K
AstraZeneca$4K
Pfizer$2K
Medtronic$1K
Baxter Healthcare$634
GSK$513
plus $2K from 18 others

$152,422in research payments, 2019–2025

Across 11 payments — averaging $13,857 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Merck$119K
Immunogen, Inc.$19K
AbbVie$15K

What the payments were for

Consulting fees$4,90023%
Speaking & faculty fees$5002%
Travel & lodging$2,14310%
Food & beverage$6,07728%
Education$8,06537%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intuitive Surgical	30	$11,452
AstraZeneca	17	$3,570
Pfizer	2	$2,178
Medtronic	13	$1,455
Baxter Healthcare	8	$634
GSK	16	$513
Eisai Inc.	5	$432
AbbVie	3	$272
Genmab U.S., Inc.	4	$186
Stryker	1	$156
Tesaro, Inc.	1	$125
Coopersurgical, Inc.	1	$120
Daiichi Sankyo Inc.	1	$120
Merck	7	$99
Tempus AI, Inc	3	$62
Aspira Women's Health Inc	1	$60
Seagen Inc.	2	$45
Genentech USA, Inc.	2	$37
Clovis Oncology, Inc.	3	$37
Incyte Corporation	2	$36
Johnson & Johnson	1	$30
Verastem, Inc.	1	$30
Bristol Myers Squibb	1	$20
Caris MPI, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,684 in reported general payments places this provider in the 95th percentile of 28 gynecologic oncology providers in Kentucky.

See all gynecologic oncology providers in Kentucky →

Medicare billing

Part B allowed, 2024

$41,083

Medicare patients

Services billed

231

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ondansetron Hcl	35	$1,348
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	16	$323
Letrozole	22	$199
Oxycodone Hcl	37	$162
Ibuprofen	12	$71
Promethazine Hcl	16	$54

Paid to pharmacies, not to this prescriber.

Other gynecologic oncology in Louisville

Daniel MetzingerLouisville$11K
Whitney GoldsberryLouisville$6K
Sarah ToddLouisville$6K
David DoeringLouisville$4K
Mary GordinierLouisville$2K
Erica TakimotoLouisville$2K
Justin GorskiLouisville$1K
Daniel MargulLouisville$1K
Jeffrey GoldbergLouisville$1K
Steven PursellLouisville$341

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →